GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $256,000 | -9.9% | 6,706 | -6.0% | 0.02% | -10.5% |
| Q2 2021 | $284,000 | -13.4% | 7,136 | -22.3% | 0.02% | -20.8% |
| Q1 2021 | $328,000 | -23.2% | 9,180 | -21.0% | 0.02% | -27.3% |
| Q4 2020 | $427,000 | -2.7% | 11,617 | -0.8% | 0.03% | -13.2% |
| Q3 2020 | $439,000 | +10.6% | 11,705 | +20.2% | 0.04% | 0.0% |
| Q2 2020 | $397,000 | -5.9% | 9,739 | -12.5% | 0.04% | -20.8% |
| Q1 2020 | $422,000 | -41.9% | 11,126 | -28.0% | 0.05% | -29.4% |
| Q4 2019 | $726,000 | +3.4% | 15,444 | -6.1% | 0.07% | -9.3% |
| Q3 2019 | $702,000 | -6.6% | 16,450 | -12.4% | 0.08% | -3.8% |
| Q2 2019 | $752,000 | +2.7% | 18,778 | +7.2% | 0.08% | -2.5% |
| Q1 2019 | $732,000 | +10.4% | 17,509 | +0.9% | 0.08% | -2.4% |
| Q4 2018 | $663,000 | – | 17,355 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |